Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Schein to license proprietary chelating compound from SunPharm

Oct. 8, 1999

Carbamazepine for the prevention and treatment of alcohol withdrawal syndrome

Sep. 28, 1999

NIDA study sheds new insight on cocaine addiction process

Sep. 23, 1999

Nalmefene reduces relapse to heavy drinking

Sep. 22, 1999

MedImmune licenses catalytic antibody against cocaine

Sep. 17, 1999

Sublingual nicotine tablets as alternative to Nicorette gum: clinical results reported at FIP '99

Sep. 8, 1999

Ferriprox approved in Europe as second-line thalassemia therapy

Aug. 27, 1999

Advances in the immunotherapy of cocaine abuse at Scripps Research Institute

Aug. 26, 1999

Academic researchers identify MAb as effective treatment for PCP addiction

Aug. 25, 1999

New treatments for alcoholism reported by Lipha

Aug. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...